Nivolumab,Oxaliplatin,Capecitabine,gimeracil,oteracil,tegafur
ono pharma,BMS,nordic group,otsuka
['nivo', 'gastric', 'nivolumab']
no improvement of rfs from nivolumab when added to postop chemo in resectable gastric cancer. unfortunately, there was no stratification by pd-l1 expression. #asco23 
Oncologue médical/Hématologue, sarcomes et tumeurs digestives|Medical oncologist/Hematologist, sarcomas and GI cancers|Dana-Farber/Harvard. Personal account.